Share this @internewscast.com

At least three Americans have been reported hospitalized after using suspected counterfeits of semaglutide drugs, which include Novo Nordisk’s diabetes medication Ozempic, according to records released by the Food and Drug Administration. 

Ozempic and Wegovy, another semaglutide medication from Novo Nordisk, have been in short supply for months amid booming sales for their use in weight loss. 

The hospitalizations are among 42 reports to the FDA’s Adverse Event Reporting System that mention use of counterfeit semaglutide from around the world. The agency last updated its database at the end of last month to include reports tallied through the end of September.

Of the reports, 28 are classified as “serious” with outcomes that also include deaths. 

Only a portion of those specifically mention Ozempic, including one of the three U.S. hospitalizations. All were submitted to the FDA by Novo Nordisk, citing reports to the company by either consumers or health care providers. 

The records do not prove whether the counterfeits caused the complaints or might have been incidental to the report. 

An FDA spokesperson said the agency has “no new information to share regarding reports of adverse events” linked to semaglutide counterfeits.

“The FDA will investigate any report of suspect counterfeit drugs to determine the public health risks and the appropriate regulatory response. The FDA remains vigilant in protecting the U.S. drug supply from these threats,” Jeremy Kahn, the spokesperson, said in an email.

The reports come as authorities around the world say they have been battling a wave of these counterfeit drugs.

Late last month, the FDA’s British counterpart — the Medicines and Health Products Regulatory Agency — said it had seized hundreds of “potentially fake Ozempic pens since January 2023.” 

The agency said it had also received reports of “a very small number who have been hospitalized” after using the counterfeits. 

The FDA has also been investigating schemes trafficking counterfeit pens into U.S. pharmacies, according to an industry trade group’s warning, previously reported by CBS News.

What counts as a counterfeit?

In June, Novo Nordisk said it was working with the FDA after a retail pharmacy in the U.S. sold an Ozempic pen that turned out to be counterfeit.

That medication came packaged in a fake label and carton that could be mistaken for an authentic Ozempic pen from Novo Nordisk, though the drugmaker said there were some telltale differences that could help patients figure out that they had bought a counterfeit.

“In close collaboration with FDA, we have taken measures to create awareness of the potential for counterfeit products. We have developed a company press statement that is posted on our U.S. corporate website and includes a guide for identifying counterfeits,” a Novo Nordisk spokesperson said in an email.

However, it is not clear if all of Novo Nordisk’s reports to the FDA’s adverse event system include knockoffs designed to dupe people into thinking they were buying authentic Ozempic.

One entry — tagged as “product label counterfeit” — references a 2020 letter from British doctors who had treated a patient who’d purchased a product called only “skinny pen plus” online. 

The FDA has also voiced concerns over semaglutide alternatives, some of which are manufactured by drug compounders like pharmacies. While compounders are allowed to sell unapproved semaglutide to Americans during the shortage, those aren’t subject to the same level of FDA oversight as Ozempic and Wegovy.

“FDA has received an increased number of adverse event reports and complaints concerning these compounded drug products,” the agency wrote in a letter last month to pharmacy boards.

Share this @internewscast.com
You May Also Like

Doctors Dismissed My Heart Flutter as Anxiety, Until I Coughed Up Blood

Lindsay Herriott, 40, had an easy pregnancy, giving birth in September 2022…

Distinguishing Between Heat Exhaustion and Sunstroke: A Doctor Explains

Dr Angela Rai, GP at The London General Practice, spoke exclusively to…

“I Tried Removing My Rotten Teeth with a Shoelace – It Wasn’t as Easy as I Expected”

A man who ‘sawed out’ his rotten teeth with a shoelace has…

US State Faces Outbreak of Rare Medieval Disease, Officials Caution on Potential Future Cases

An Arizona resident had succumbed to the Black Death, marking the county’s…

Artificial Sweetener Potentially Connected to Highly Aggressive Brain Cancer

A recent Chinese study has uncovered a concerning relationship between aspartame, a…

Starmer’s NHS Strategy Overlooks Key Issue: My Daughter Passed Away After 6-Hour Ambulance Delay

A dad who lost his daughter after a six-hour ambulance wait has…

Unexpected Questions That Arise When Facing Incurable Cancer

Lying peacefully on the bed the man smiled and quietly exclaimed he…

Groundbreaking Discovery in Alzheimer’s Treatment Could Revolutionize Disease Cure

Scientists have uncovered a new group of rogue proteins in the brain…

Faulty Tests Drive Silent Epidemic Across the US, Putting Thousands at Risk for Chronic Diseases

Thousands could be at risk of suffering from a chronic disease this…

Widely Used Supplement Causes Liver Damage, Leaving One Woman Hospitalized

A New Jersey woman has vowed never to take a supplement again…

Eliminating Guilt and Finding Hope: An NHS Change That Makes a Difference

Sometimes I feel guilty that I haven’t died yet. This isn’t the…